Advertisement

Reactions Weekly

, Volume 1731, Issue 1, pp 150–150 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Various toxicities: 17 case reports
Case report

Reference

  1. Tio M, et al. Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection. European Journal of Cancer 104: 137-144, Nov 2018. Available from: URL: http://doi.org/10.1016/j.ejca.2018.09.017 - AustraliaCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations